These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Women's Health Initiative estrogen plus progestin trial: the study and how it changes our practice. Hendrix SL J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S3-5. PubMed ID: 12625631 [No Abstract] [Full Text] [Related]
3. [Conjugated estrogen-gestagen does not reduce cardiovascular morbidity. Were these findings (in the Women's Health Initiative study) really unexpected?]. Henriksson P Lakartidningen; 2002 Nov; 99(47):4716-9. PubMed ID: 12523045 [No Abstract] [Full Text] [Related]
4. Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative. Kaunitz AM; Medscape Womens Health; 2002; 7(4):8. PubMed ID: 12466740 [No Abstract] [Full Text] [Related]
5. Be careful of what you wish for: putting the WHI Estrogen/Progestin and HERS II Trials in perspective. Randolph JF; Medscape Womens Health; 2002; 7(4):7. PubMed ID: 12466739 [No Abstract] [Full Text] [Related]
6. [Postmenopausal estrogen therapy: pharmacological treatment or replacement of the lacking hormone?]. Lippert TH; Seeger H; Mueck AO Dtsch Med Wochenschr; 1999 Oct; 124(42):1245-8. PubMed ID: 10572534 [No Abstract] [Full Text] [Related]
7. Optimizing the dose of hormone replacement therapy. Rice VM Int J Fertil Womens Med; 2002; 47(5):205-10. PubMed ID: 12469707 [TBL] [Abstract][Full Text] [Related]
8. [Treatment with estrogen]. Ingelman-Sundberg A Lakartidningen; 2002 Nov; 99(47):4777-8. PubMed ID: 12523062 [No Abstract] [Full Text] [Related]
9. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy]. Stjernquist M; Lakartidningen; 2003 May; 100(20):1790-7. PubMed ID: 12806859 [TBL] [Abstract][Full Text] [Related]
10. Do risks of hormone therapy persist after discontinuation? J Fam Pract; 2008 Jun; 57(6):366, 369. PubMed ID: 18677802 [No Abstract] [Full Text] [Related]
11. Low-dose hormone therapy in postmenopausal women in China. Zang H; Shi H; Speroff L Climacteric; 2010 Dec; 13(6):544-52. PubMed ID: 19938946 [TBL] [Abstract][Full Text] [Related]
13. Health risks outweigh benefits for combined estrogen plus progestin. Clinical trial stopped early in major study. American Medical Association Ginecol Obstet Mex; 2002 Aug; 70():411-2. PubMed ID: 12449905 [No Abstract] [Full Text] [Related]
14. [Some problems of postmenopausal osteoporosis prevention with hormone replacement therapy]. Liu JL Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):240-3. PubMed ID: 12905731 [TBL] [Abstract][Full Text] [Related]
15. The Heart and Estrogen/Progestin Replacement Study (HERS) in perspective--results not very surprising. Naessen T Acta Obstet Gynecol Scand; 2000 Dec; 79(12):1037-41. PubMed ID: 11130083 [No Abstract] [Full Text] [Related]